Study of Crohn’s and colitis medicines during pregnancy and breastfeeding
Part of Digestive system clinical trials.
This registry study tracks outcomes for mothers with inflammatory bowel disease (IBD) and their babies during pregnancy and breastfeeding while using IBD medicines. It aims to better understand the safety of these medicines so future pregnancies can be managed more confidently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Have a diagnosis of IBD (Crohn’s disease or ulcerative colitis)
- Be currently pregnant
- Know and report the pregnancy to the study team before 28 weeks of pregnancy
- Agree to participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how pregnancy affects and is affected by inflammatory bowel disease. It aims to learn more to help women with IBD who are or want to become pregnant.
This study looks at gut health in pregnant women with and without inflammatory bowel disease (IBD). It tracks a protein called calprotectin in stool samples, along with diet and baby health, to learn how IBD affects pregnancy and infant development.
This trial collects information from children who are newly diagnosed with inflammatory bowel disease (IBD) and follows them to understand safety in real life. It may help doctors improve early diagnosis and treatment planning for kids with IBD.
This study looks at how plastics and toxins in the environment might affect inflammation in the gut, especially in pregnant women with Crohn's disease and their families. It will help doctors understand if these chemicals play a role in bowel inflammation during pregnancy.
This study follows adults with Crohn’s disease or ulcerative colitis when their treatment is changed. It collects health information and samples to better understand how treatment changes affect people over time.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.